|
G |
Crp |
C-reactive protein |
decreases expression |
ISO |
Colesevelam Hydrochloride results in decreased expression of CRP protein |
CTD |
PMID:16616026 |
|
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions increases expression |
ISO |
Colesevelam Hydrochloride promotes the reaction [Simvastatin results in increased expression of HMGCR mRNA] Colesevelam Hydrochloride results in increased expression of HMGCR mRNA |
CTD |
PMID:22120639 |
|
NCBI chr 2:27,480,224...27,500,654
Ensembl chr 2:27,480,226...27,500,654
|
|
G |
Ldlr |
low density lipoprotein receptor |
increases expression |
ISO |
Colesevelam Hydrochloride results in increased expression of LDLR mRNA |
CTD |
PMID:22120639 |
|
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
|
G |
C3 |
complement C3 |
increases expression |
ISO |
styrofoam analog results in increased expression of C3 protein |
CTD |
PMID:19428933 |
|
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C5 |
complement C5 |
increases expression |
ISO |
styrofoam analog results in increased expression of C5 protein |
CTD |
PMID:19428933 |
|
NCBI chr 3:14,049,993...14,113,931 NCBI chr 3:14,206,466...14,229,141
Ensembl chr 3:14,049,995...14,229,080
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions affects activity |
ISO |
styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP1A2 protein] styrofoam analog affects the activity of CYP1A2 protein |
CTD |
PMID:19909766 |
|
NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity multiple interactions |
ISO |
styrofoam analog results in decreased activity of CYP2D6 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP2D6 protein] |
CTD |
PMID:19909766 |
|
NCBI chr 7:123,599,264...123,608,436
Ensembl chr 7:123,599,266...123,608,436
|
|
G |
Cyp3a62 |
cytochrome P450, family 3, subfamily a, polypeptide 62 |
decreases activity multiple interactions |
ISO |
styrofoam analog results in decreased activity of CYP3A4 protein styrofoam analog promotes the reaction [Cimetidine results in decreased activity of CYP3A4 protein] |
CTD |
PMID:19909766 |
|
NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397
|
|
G |
Itgam |
integrin subunit alpha M |
increases expression |
ISO |
styrofoam analog results in increased expression of ITGAM protein |
CTD |
PMID:19428933 |
|
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
|
|
G |
Pf4 |
platelet factor 4 |
increases secretion |
ISO |
styrofoam analog results in increased secretion of PF4 protein |
CTD |
PMID:19428933 |
|
NCBI chr14:18,848,549...18,849,258
Ensembl chr14:18,848,549...18,849,258
|
|
G |
Ppbp |
pro-platelet basic protein |
increases secretion |
ISO |
styrofoam analog results in increased secretion of PPBP protein |
CTD |
PMID:19428933 |
|
NCBI chr14:18,852,433...18,853,237
Ensembl chr14:18,851,954...18,853,315
|
|
G |
Selp |
selectin P |
increases expression |
ISO |
styrofoam results in increased expression of SELP protein |
CTD |
PMID:21123846 |
|
NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
|
|
|
G |
Angpt1 |
angiopoietin 1 |
decreases expression |
ISO |
Polyvinyl Chloride results in decreased expression of ANGPT1 mRNA |
CTD |
PMID:12809767 |
|
NCBI chr 7:81,338,327...81,592,459
Ensembl chr 7:81,342,280...81,592,206
|
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of ATP5MC2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 7:144,264,207...144,272,578
Ensembl chr 7:144,264,199...144,272,578
|
|
G |
Bola3 |
bolA family member 3 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of BOLA3 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 4:115,046,693...115,056,140
Ensembl chr 4:115,046,693...115,056,140
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[Silver co-treated with Povidone] affects the expression of CASP3 protein; [Silver co-treated with Povidone] results in decreased expression of CASP3 mRNA |
CTD |
PMID:27387714 |
|
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
ISO |
[Silver co-treated with Povidone] results in decreased expression of CDKN1A mRNA; [Silver co-treated with Povidone] results in decreased expression of CDKN1A protein |
CTD |
PMID:27387714 |
|
NCBI chr20:6,348,422...6,358,864
Ensembl chr20:6,351,458...6,358,864
|
|
G |
Col8a1 |
collagen type VIII alpha 1 chain |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of COL8A1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr11:44,877,690...45,006,203
Ensembl chr11:44,877,859...45,007,891
|
|
G |
Cox17 |
cytochrome c oxidase copper chaperone COX17 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of COX17 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr11:64,962,663...64,968,437
Ensembl chr11:64,962,666...64,968,437
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of CYP1A1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147
|
|
G |
Dad1 |
defender against cell death 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of DAD1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr15:32,868,136...32,887,933
Ensembl chr15:32,868,087...32,888,095
|
|
G |
Gbp2 |
guanylate binding protein 2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of GBP2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 2:248,276,795...248,293,784
Ensembl chr 2:248,276,709...248,293,784
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions |
ISO |
[Silver co-treated with Povidone] results in increased expression of H2AX protein modified form |
CTD |
PMID:27387714 |
|
NCBI chr 8:48,665,652...48,666,981
Ensembl chr 8:48,665,652...48,666,981
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of HMOX1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of IFIT3 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 1:252,906,234...252,911,377
Ensembl chr 1:252,906,234...252,911,382
|
|
G |
Lims1 |
LIM zinc finger domain containing 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of LIMS1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr20:27,895,981...28,004,767
Ensembl chr20:27,954,433...28,002,082
|
|
G |
Lmnb2 |
lamin B2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of LMNB2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 7:11,657,870...11,676,936
Ensembl chr 7:11,660,934...11,675,472
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK1 protein |
CTD |
PMID:21729742 |
|
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
[Silver Compounds co-treated with Povidone] results in increased activity of MAPK3 protein |
CTD |
PMID:21729742 |
|
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
multiple interactions |
ISO |
[Silver co-treated with Povidone] affects the expression of MDM2 protein; [Silver co-treated with Povidone] results in decreased expression of MDM2 mRNA |
CTD |
PMID:27387714 |
|
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] affects the expression of MT1A mRNA |
CTD |
PMID:25194297 |
|
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
|
|
G |
Nfix |
nuclear factor I X |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of NFIX mRNA |
CTD |
PMID:25194297 |
|
NCBI chr19:25,818,640...25,914,777
Ensembl chr19:25,821,780...25,914,696
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of NQO1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nrm |
nurim |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of NRM mRNA |
CTD |
PMID:25194297 |
|
NCBI chr20:3,397,834...3,402,264
Ensembl chr20:3,397,834...3,401,315
|
|
G |
Nuak2 |
NUAK family kinase 2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr13:49,092,306...49,109,055
Ensembl chr13:49,092,306...49,109,050
|
|
G |
Ocln |
occludin |
affects expression |
ISO |
Povidone affects the expression of OCLN mRNA |
CTD |
PMID:19729060 |
|
NCBI chr 2:30,527,327...30,577,218
Ensembl chr 2:30,527,715...30,577,218
|
|
G |
Prpf38b |
pre-mRNA processing factor 38B |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of PRPF38B mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 2:211,706,245...211,715,271
Ensembl chr 2:211,706,228...211,715,311
|
|
G |
Prr13 |
proline rich 13 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of PRR13 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 7:144,064,931...144,068,235
Ensembl chr 7:144,064,931...144,098,101
|
|
G |
Psenen |
presenilin enhancer gamma secretase subunit |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of PSENEN mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 1:89,016,093...89,017,449
Ensembl chr 1:89,016,096...89,017,290
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of PTGS2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
multiple interactions |
ISO |
[Silver Compounds co-treated with Povidone] results in increased activity of PTK2 protein |
CTD |
PMID:21729742 |
|
NCBI chr 7:114,436,419...114,611,317
Ensembl chr 7:114,437,361...114,590,119
|
|
G |
Rab14 |
RAB14, member RAS oncogene family |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of RAB14 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 3:14,373,270...14,395,357
Ensembl chr 3:14,373,275...14,395,362
|
|
G |
Rbm25l1 |
RNA binding motif protein 25-like 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of RBM25L1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr10:10,457,316...10,460,540
Ensembl chr10:10,457,320...10,460,756
|
|
G |
Selenow |
selenoprotein W |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of SELENOW mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 1:77,530,692...77,535,765
Ensembl chr 1:77,533,148...77,535,681 Ensembl chr 1:77,533,148...77,535,681
|
|
G |
Slc5a3 |
solute carrier family 5 member 3 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of SLC5A3 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr11:32,229,366...32,231,812
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
[Silver co-treated with Povidone] results in increased expression of SOD2 mRNA; [Silver co-treated with Povidone] results in increased expression of SOD2 protein |
CTD |
PMID:27387714 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of SPARC mRNA |
CTD |
PMID:25194297 |
|
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of STAT2 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 7:2,691,064...2,707,530
Ensembl chr 7:2,691,369...2,707,741
|
|
G |
Sv2b |
synaptic vesicle glycoprotein 2b |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of SV2B mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 1:136,664,199...136,842,247
Ensembl chr 1:136,664,204...136,842,247
|
|
G |
Tiparp |
TCDD-inducible poly(ADP-ribose) polymerase |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of TIPARP mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 2:157,316,293...157,342,979
Ensembl chr 2:157,316,266...157,341,469
|
|
G |
Tmtc3 |
transmembrane O-mannosyltransferase targeting cadherins 3 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of TMTC3 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 7:40,171,957...40,217,056
Ensembl chr 7:40,171,963...40,217,056
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
ISO |
[Silver co-treated with Povidone] affects the phosphorylation of TP53 protein; [Silver co-treated with Povidone] results in decreased expression of TP53 mRNA; [Silver co-treated with Povidone] results in decreased expression of TP53 protein |
CTD |
PMID:27387714 |
|
NCBI chr10:56,186,299...56,198,449
Ensembl chr10:56,187,020...56,198,449
|
|
G |
Trappc1 |
trafficking protein particle complex subunit 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in decreased expression of TRAPPC1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr10:55,924,996...55,926,582
Ensembl chr10:55,924,938...55,926,783
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
ISO |
[Silver Compounds co-treated with Povidone] results in increased expression of VEGFA protein |
CTD |
PMID:21729742 |
|
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
|
|
G |
Wdfy1 |
WD repeat and FYVE domain containing 1 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of WDFY1 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr 9:85,477,070...85,528,885
Ensembl chr 9:85,475,841...85,528,869
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
multiple interactions |
EXP |
[Silver analog co-treated with Povidone] results in increased expression of ZFHX3 mRNA |
CTD |
PMID:25194297 |
|
NCBI chr19:42,753,983...42,925,794
Ensembl chr19:42,758,127...42,920,344
|
|